Hitomi Mori

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

A Case of Hormone Receptor-Positive, HER2-Negative Metastatic Recurrent Breast Cancer Successfully Treated with Capivasertib and Fulvestrant in Late-Line Therapy

A Case of Hormone Receptor-Positive, HER2-Negative Metastatic Recurrent Breast Cancer Successfully Treated with Capivasertib and Fulvestrant in Late-Line Therapy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026

Molecular features of luminal breast cancer defined through spatial and single-cell transcriptomics.

Molecular features of luminal breast cancer defined through spatial and single-cell transcriptomics.

Journal: Clinical and translational medicine
Published: April 26, 2023

Identification and characterization of a proliferative cell population in estrogen receptor-positive metastatic breast cancer through spatial and single-cell transcriptomics.

Identification and characterization of a proliferative cell population in estrogen receptor-positive metastatic breast cancer through spatial and single-cell transcriptomics.

Journal: bioRxiv : the preprint server for biology
Published: February 13, 2023

Influence of Estrogen Treatment on ESR1+ and ESR1- Cells in ER+ Breast Cancer: Insights from Single-Cell Analysis of Patient-Derived Xenograft Models.

Influence of Estrogen Treatment on ESR1+ and ESR1- Cells in ER+ Breast Cancer: Insights from Single-Cell Analysis of Patient-Derived Xenograft Models.

Journal: Cancers
Published: November 19, 2021

Comprehensive molecular profiling broadens treatment options for breast cancer patients.

Comprehensive molecular profiling broadens treatment options for breast cancer patients.

Journal: Cancer medicine
Published: August 20, 2020

Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients.

Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients.

Journal: Cancer medicine
Published: July 20, 2020

Microsatellite instability in Japanese female patients with triple-negative breast cancer.

Microsatellite instability in Japanese female patients with triple-negative breast cancer.

Journal: Breast cancer (Tokyo, Japan)
Published: August 05, 2019

T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer.

T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer.

Journal: Breast cancer research and treatment
Published: February 02, 2019

Significance of Endocrine Therapy for Unresected Primary Breast Cancer

Significance of Endocrine Therapy for Unresected Primary Breast Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: November 20, 2018

QOL-enhancing surgery for patients with HER2-positive metastatic breast cancer.

QOL-enhancing surgery for patients with HER2-positive metastatic breast cancer.

Journal: BMJ supportive & palliative care
Published: July 26, 2018

Efficacy and Safety of Bi-weekly Pegfilgrastim for Dose-dense Chemotherapy-induced Neutropenia in Breast Cancer Patients.

Efficacy and Safety of Bi-weekly Pegfilgrastim for Dose-dense Chemotherapy-induced Neutropenia in Breast Cancer Patients.

Journal: Anticancer research
Published: April 11, 2018

Catumaxomab with Activated T-cells Efficiently Lyses Chemoresistant EpCAM-positive Triple-negative Breast Cancer Cell Lines.

Catumaxomab with Activated T-cells Efficiently Lyses Chemoresistant EpCAM-positive Triple-negative Breast Cancer Cell Lines.

Journal: Anticancer research
Published: April 11, 2018
Showing 1-12 of 15

Last Updated: 09/26/2026